Rare inborn errors of metabolism

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

2 events
Jun 2020Rare Obesity Cohorts With Food Behavioral Disorders : Better Diagnosis for Better Treatment

Assistance Publique - Hôpitaux de Paris

TrialRECRUITING
Mar 2015Cholbam: FDA approved

Treatment of bile acid synthesis disorders due to single enzyme defects

FDAcompleted

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Rare inborn errors of metabolism.
Check the disease page for updates →

Approved Treatments

1 FDA-approved

Cholbam

(CHOLIC ACID)Orphan drug

Mirum Pharmaceuticals Inc.

Bile Acid [EPC]

12.1 Mechanism of Action Cholic acid is a primary bile acid synthesized from cholesterol in the liver. In bile acid synthesis disorders due to SEDs in...

Approved Mar 2015FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Rare inborn errors of metabolism.
Search all trials →
Search clinical trials for Rare inborn errors of metabolism

Recent News & Research

No recent news articles indexed yet for Rare inborn errors of metabolism.
Search PubMed for Rare inborn errors of metabolism

Browse all Rare inborn errors of metabolism news →

Specialist Network

Top 6 by expertise

View all Rare inborn errors of metabolism specialists →

Quick Actions